Taurine attenuates oxidative stress and alleviates cardiac failure in type 1 diabetic rats

Croatian Medical Journal

Volumn 54, Issue 2, 2013, Pages 171-179

  Wang, Guo guang ^a   Li, Wei ^a   Lu, Xiao hua ^a   Zhao, Xue ^a   Xu, Lei ^a  

^a WANNAN MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BUFFER; CHOLESTEROL; CITRIC ACID; CONNECTIVE TISSUE GROWTH FACTOR; CREATINE KINASE; GLUCOSE; HEME OXYGENASE 1; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE; PROTEIN KINASE B; STREPTOZOCIN; SUPEROXIDE DISMUTASE; TAURINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETIC CARDIOMYOPATHY; DIASTOLIC BLOOD PRESSURE; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; HEART FAILURE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE PRESSURE; HEART LEFT VENTRICLE RELAXATION; HEART MUSCLE CONTRACTILITY; HEART PROTECTION; HEART WEIGHT; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WESTERN BLOTTING;

ANIMALS; BLOOD GLUCOSE; BLOTTING, WESTERN; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DIABETIC CARDIOMYOPATHIES; HEART FAILURE; HEME OXYGENASE-1; MALE; MALONDIALDEHYDE; ORGAN SIZE; OXIDATION-REDUCTION; OXIDATIVE STRESS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDE DISMUTASE; TAURINE;

EID: 84878197549     PISSN: 03539504     EISSN: 13328166     Source Type: Journal    
DOI: 10.3325/cmj.2013.54.171     Document Type: Article

References (43)

1. Picano E. Diabetic cardiomyopathy: the importance of being earliest. J Am Coll Cardiol. 2003;42:454-7. Medline:12906971 doi:10.1016/S0735-1097(03)00647-8
2. Rubler S, Dlugash J, Yuceoglu YZ, Kumral T, Branwood AW, Grishman A. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol. 1972;30:595-602. Medline:4263660 doi:10.1016/0002-9149(72)90595-4
3. Devereux RB, Roman MJ, Paranicas M, O'Grady MJ, Lee ET , Welty TK, et al. Impact of diabetes on cardiac structure and function: the strong heart study. Circulation. 2000;101:2271-6. Medline:10811594 doi:10.1161/01.CIR.101.19.2271
4. Anuradha CV, Ravikumar P. Restoration on tissue antioxidants by fenugreek seeds (Trigonella Foenum Graecum) in alloxandiabetic rats. Indian J Physiol Pharmacol. 2001;45:408-20. Medline:11883146
5. Nishikawa T, Edelstein D, Du XL, Yamagishi SI, Matsumura T, Kaneda Y, et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycemic damage. Nature. 2000;404:787- 90. Medline:10783895 doi:10.1038/35008121
6. Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Are oxidative stress-activated signaling pathways mediators of insulin resistance and β-cell dysfunction? Diabetes. 2003;52:1-8. Medline:12502486 doi:10.2337/diabetes.52.1.1
7. Kameda K, Matsunaga T, Abe N, Hanada H, Ishizaka H, Ono H, et al. Correlation of oxidative stress with activity of matrix metalloproteinase in patients with coronary artery disease: possible role for left ventricular remodeling. Eur Heart J. 2003;24:2180-5. Medline:14659769 doi:10.1016/j.ehj.2003.09.022
8. Wang Y, Feng W, Xue W, Tan Y, Hein DW, Li XK, et al. Inactivation of GSK-3beta by metallothionein prevents diabetes-related changes in cardiac energy metabolism, inflammation, nitrosative damage, and remodeling. Diabetes. 2009;58:1391-402. Medline:19324938 doi:10.2337/db08-1697
9. Cai L, Wang J, Li Y, Sun X, Wang L, Zhou Z, et al. Inhibition of superoxide generation and associated nitrosative damage is involved in metallothionein prevention of diabetic cardiomyopathy. Diabetes. 2005;54:1829-37. Medline:15919806 doi:10.2337/diabetes.54.6.1829
10. Ryter SW, Alam J, Choi AM. Heme oxygenase/carbon monoxide: From basic science to therapeutic application. Physiol Rev. 2006;86:583-650. Medline:16601269 doi:10.1152/ physrev.00011.2005
11. S tocker R, Yamamoto Y, Mcdonagh AF, Glazer AN, Ames BN. Bilirubin is an antioxidant of possible physiological significance. Science. 1987;235:1043-6. Medline:3029864 doi:10.1126/ science.3029864
12. O tterbein LE, Bach FH, Alam J, Soares M, Lu HT, Wysk M, et al. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med. 2000;6:422-8. Medline:10742149 doi:10.1038/74680
13. Di Noia MA, Van Driesche S, Palmieri F, Yang LM, Quan S, Goodman AI, et al. Heme oxygenase-1 enhances renal mitochondrial transport carriers and cytochrome C oxidase activity in experimental diabetes. J Biol Chem. 2006;281:15687-93. Medline:16595661 doi:10.1074/jbc.M510595200
14. Kim DH, Burgess AP, Li M, Tsenovoy PL, Addabbo F, McClung JA, et al. Heme oxygenase-mediated increases in adiponectin decrease fat content and inflammatory cytokines tumor necrosis factoralpha and interleukin-6 in Zucker rats and reduce adipogenesis in human mesenchymal stem cells. J Pharmacol Exp Ther. 2008;325:833-40. Medline:18334666 doi:10.1124/jpet.107.135285
15. Hardie DG. Minireview: The AMP-activated protein kinase cascade: The key sensor of cellular energy status. Endocrinology. 2003;144:5179-83. Medline:12960015 doi:10.1210/en.2003-0982
16. Hardie DG. AMP-activated protein kinase as a drug target. Annu Rev Pharmacol Toxicol. 2007;47:185-210. Medline:16879084 doi:10.1146/annurev.pharmtox.47.120505.105304
17. Skurk C, Maatz H, Kim HS, Yang J, Abid MR, Aird WC, et al. The Akt-regulated forkhead transcription factor FOXO3a controls endothelial cell viability through modulation of the caspase-8 inhibitor FLIP. J Biol Chem. 2004;279:1513-25. Medline:14551207 doi:10.1074/jbc.M304736200
18. Hansen SH. The role of taurine in diabetes and the development of diabetic complications. Diabetes Metab Res Rev. 2001;17:330-46. Medline:11747139 doi:10.1002/dmrr.229
19. Balkan J, Kanbagli O, Hatipoglu A, Kucuk M, Cevikbas U, Aykac-Toker G, et al. Improving effect of dietary taurine supplementation on the oxidative stress and lipid levels in the plasma, liver and aorta of rabbits fed on a high-cholesterol diet. Biosci Biotechnol Biochem. 2002;66:1755-8. Medline:12353642 doi:10.1271/ bbb.66.1755
20. Cetiner M, Sener G, Sehirli AO , Eksioglu-Demiralp E, Ercan F, Sirvaci S, et al. Taurine protects against methotrexate-induced toxicity and inhibits leucocyte death. Toxicol Appl Pharmacol. 2005;209:39-50. Medline:15890378 doi:10.1016/j.taap.2005.03.009
21. Tikoo K, Tripathi DN, Kabra DG, Sharma V, Gaikwad AB. Intermittent fasting prevents the progression of type I diabetic nephropathy in rats and changes the expression of Sir2 and p53. FEBS Lett. 2007;581:1071-8. Medline:17316625 doi:10.1016/j. febslet.2007.02.006
22. Yahagi N, Shimano H, Hasty AH, Matsuzaka T, Ide T, Yoshikawa T, et al. Absence of sterol regulatory element-binding protein-1 (SREBP-1) ameliorates fatty livers but not obesity or insulin resistance in Lep(ob)/Lep(ob) mice. J Biol Chem. 2002;277:19353-7. Medline:11923308 doi:10.1074/jbc.M201584200
23. Howard-Alpe GM, Sear JW, Foex P. Methods of detecting atherosclerosis in non-cardiac surgical patients; the role of biochemical markers. Br J Anaesth. 2006;97:758-69. Medline:17074779 doi:10.1093/bja/ael303
24. Vincent AM, Brownlee M, Russell JW. Oxidative stress and programmed cell death in diabetic neuropathy. Ann N Y Acad Sci. 2002;959:368-83. Medline:11976211 doi:10.1111/j.1749-6632.2002. tb02108.x
25. Nandhini AT , Thirunavukkarasu V, Ravichandran MK, Anuradha CV. Effect of taurine on biomarkers of oxidative stress in tissues of fructose-fed insulin-resistant rats. Singapore Med J. 2005;46:82-7. Medline:15678290
26. Li C, Cao L, Zeng Q, Liu X, Zhang Y, Dai T, et al. Taurine may prevent diabetic rats from developing cardiomyopathy also by downregulating angiotensin II type2 receptor expression. Cardiovasc Drugs Ther. 2005;19:105-12. Medline:16025228 doi:10.1007/s10557-005-0443-x
27. Tappia PS, Thliveris J, Xu YJ, Aroutiounova N, Dhalla NS. Effects of amino acid supplementation on myocardial cell damage and cardiac function in diabetes. Exp Clin Cardiol. 2011;16:e17-22. Medline:22065942
28. Manthey KC, Chew YC, Zempleni J. Riboflavin deficiency impairs oxidative folding and secretion of apolipoprotein B-100 in HepG2 cells, triggering stress-response systems. J Nutr. 2005;135:978-82. Medline:15867268
29. Oriyanhan W, Yamazaki K, Miwa S, Takaba K, Ikeda T, Komeda M. Taurine prevents myocardial ischemia/reperfusion-induced oxidative stress and apoptosis in prolonged hypothermic rat heart preservation. Heart Vessels. 2005;20:278-85. Medline:16314910 doi:10.1007/s00380-005-0841-9
30. Leite AC, Araújo TG, Carvalho BM, Silva NH, Lima VL, Maia MB. Parkinsonia aculeata aqueous extract fraction: biochemical studies in alloxan induced diabetic rats. J Ethnopharmacol. 2007;111:547-52. Medline:17276638 doi:10.1016/j.jep.2006.12.032
31. Keul P, Sattler K, Levkau B. HDL and its sphingosine-1-phosphate content in cardioprotection. Heart Fail Rev. 2007;12:301-6. Medline:17554629 doi:10.1007/s10741-007-9038-x
32. Manthey KC, Chew YC, Zempleni J. Riboflavin deficiency impairs oxidative folding and secretion of apolipoprotein B-100 in HepG2 cells, triggering stress-response systems. J Nutr. 2005;135:978-82. Medline:15867268
33. Matsui T, Rosenzweig A. Convergent signal transduction pathways controlling cardiomyocyte survival and function: the role of PI 3-kinase and Akt. J Mol Cell Cardiol. 2005;38:63-71. Medline:15623422 doi:10.1016/j.yjmcc.2004.11.005
34. Pachori AS, Smith A, McDonald P, Zhang L, Dzau VJ, Melo LG. Heme-Oxygenase-1 Induced Protection Against Hypoxia/ Reoxygenation is Dependent on Biliverdin Reductase and its Interaction with PI3K/Akt Pathway. J Mol Cell Cardiol. 2007;43:580-92. Medline:17920074 doi:10.1016/j.yjmcc.2007.08.003
35. Geraldes P, Yagi K, Ohshiro Y, He Z, Maeno Y, Yamamoto-Hiraoka J, et al. Selective Regulation of Heme Oxygenase-1 Expression and Function by Insulin through IRS1/Phosphoinositide 3-Kinase/ Akt-2 Pathway. J Biol Chem. 2008;283:34327-36. Medline:18854316 doi:10.1074/jbc.M807036200
36. Han Z, Varadharaj S, Giedt RJ, Zweier JL, Szeto HH, Alevriadou BR. Mitochondria-derived reactive oxygen species mediate heme oxygenase-1 expression in sheared endothelial cells. J Pharmacol Exp Ther. 2009;329:94-101. Medline:19131585 doi:10.1124/ jpet.108.145557
37. Brunt KR, Fenrich KK, Kiani G, Tse MY, Pang SC, Ward CA, et al. Protection of human vascular smooth muscle cells from H2O2-induced apoptosis through functional codependence between HO-1 and AKT. Arterioscler Thromb Vasc Biol. 2006;26:2027-34. Medline:16840713 doi:10.1161/01.AT V.0000236204.37119.8d
38. Leask A, Abraham DJ. All in the CCN family: essential matricellular signaling modulators emerge from the bunker. J Cell Sci. 2006;119:4803-10. Medline:17130294 doi:10.1242/jcs.03270
39. Brigstock DR. Strategies for blocking the fibrogenic actions of connective tissue growth factor (CCN2): From pharmacological inhibition in vitro to targeted siRNA therapy in vivo. J Cell Commun Signal. 2009;3:5-18. Medline:19294531 doi:10.1007/s12079-009-0043-9
40. Hayata N, Fujio Y, Yamamoto Y, Iwakura T, Obana M, Takai M, et al. Connective tissue growth factor induces cardiac hypertrophy through Akt signaling. Biochem Biophys Res Commun. 2008;370:274-8. Medline:18375200 doi:10.1016/j.bbrc.2008.03.100
41. Vincent AM, Brownlee M, Russell JW. Oxidative stress and programmed cell death in diabetic neuropathy. Ann N Y Acad Sci. 2002;959:368-83. Medline:11976211 doi:10.1111/j.1749-6632.2002. tb02108.x
42. He Z, Way KJ, Arikawa E, Chou E, Opland DM, Clermont A, et al. Differential regulation of angiotensin II-induced expression of connective tissue growth factor by protein kinase C isoforms in the myocardium. J Biol Chem. 2005;280:15719-26. Medline:15699040 doi:10.1074/jbc.M413493200
43. Geraldes P, King GL. Activation of protein kinase C isoforms & its impact on diabetic complications. Circ Res. 2010;106:1319-31. Medline:20431074 doi:10.1161/CIRCRESAHA.110.217117